An Analysis of Canadian Institute for Health Research Funding for Research on Autism Spectrum Disorder
| dc.contributor.author | Deonandan, Raywat | |
| dc.contributor.author | Liu, Erin Yiran | |
| dc.contributor.author | Kolisnyk, Ben | |
| dc.contributor.author | Konkle, ATM | |
| dc.date.accessioned | 2016-02-22T20:30:25Z | |
| dc.date.available | 2016-02-22T20:30:25Z | |
| dc.date.issued | 2016-02-01 | |
| dc.description.abstract | We examined patterns of Canadian Institute for Health Research (CIHR) funding on autism spectrum disorder (ASD) research. From 1999 to 2013, CIHR funded 190 ASD grants worth $48 million. Biomedical research received 43% of grants (46% of dollars), clinical research 27% (41%), health services 10% (7%), and population health research 8% (3%). The greatest number of grants was given in 2009, but 2003 saw the greatest amount. Funding is clustered in a handful of provinces and institutions, favouring biomedical research and disfavouring behavioural interventions, adaptation, and institutional response. Preference for biomedical research may be due to the detriment of clinical research. | en |
| dc.identifier.citation | Autism Research and Treatment Volume 2016, Article ID 8106595 | en |
| dc.identifier.doi | http://dx.doi.org/10.1155/2016/8106595 | en |
| dc.identifier.uri | http://www.hindawi.com/journals/aurt/2016/8106595/ | en |
| dc.identifier.uri | http://hdl.handle.net/10393/34298 | |
| dc.language.iso | en | en |
| dc.subject | autism | en |
| dc.subject | funding | en |
| dc.subject | CIHR | en |
| dc.subject | canada | en |
| dc.title | An Analysis of Canadian Institute for Health Research Funding for Research on Autism Spectrum Disorder | en |
| dc.type | Article | en |
